Submit Manuscript  

Article Details

Nephroangiosclerosis and Its Pharmacological Approach

[ Vol. 9 , Issue. 2 ]


Rosario Cianci, Biagio Barbano, Paola Martina, Antonietta Gigante, Lelio Polidori, Silvia Lai, Giada Ascoli, Irene De Francesco, Domenico Di Donato, Giorgio Fuiano and Alessandro Zuccala   Pages 238 - 243 ( 6 )


Nephroangiosclerosis (NAS) is a major cause of progressive renal insufficiency. Hypertension is very important in the causation of NAS but other factors such as race, age, metabolic variables, and genetics play a pathogenic and prognostic role. A multifactorial treatment strategy, including antihypertensive, lipid-lowering and anti-platelet agents, could improve cardiovascular and renal outcomes in patients with vascular nephropathy.


Nephroangiosclerosis, vascular nephropathy, hypertension, renal failure, statins


Department of Nephrology, “Sapienza” University of Rome, Viale del Policlinico 155, Rome, Italy.

Read Full-Text article